FSCHX | PRNEX | FSCHX / PRNEX | |
Total Expense Ratio | 0.69 | 0.77 | 90% |
Annual Report Gross Expense Ratio | 0.69 | 0.77 | 90% |
Fund Existence | 40 years | 56 years | - |
Gain YTD | -5.251 | 1.534 | -342% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 2500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 452M | 2.27B | 20% |
Annual Yield % from dividends | 1.10 | 2.05 | 54% |
Returns for 1 year | -14.07 | -5.32 | 265% |
Returns for 3 years | -24.62 | -5.84 | 422% |
Returns for 5 years | 22.08 | 59.71 | 37% |
Returns for 10 years | -10.64 | 26.75 | -40% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SWHFX | 22.99 | 0.17 | +0.74% |
Schwab Health Care | |||
CDIVX | 12.09 | 0.01 | +0.08% |
Copeland Dividend Growth Fund Class I | |||
TSOPX | 14.97 | 0.01 | +0.07% |
Nuveen International Res Eq Prmr | |||
PRDSX | 41.43 | -0.04 | -0.10% |
T. Rowe Price Integrated US Sm Gr Eq | |||
RWCEX | 11.48 | -0.19 | -1.63% |
Redwheel Global Emerging Equity Ins |